Announcing the NeuroMatch Ambassador Program. Be among the first to join our closed beta.

Explore & Apply

Press Releases

NeuroMatch software user

Announcing the NeuroMatch Ambassador Program: Your Expertise, Our Innovation

We are excited to extend a special invitation to select medical professionals for the private beta launch of our latest technology.
ACNS Orlando feature image

LVIS Corporation Introduces NeuroMatch® at 2024 American Clinical Neurophysiology Society Meeting

LVIS Corporation, a leading innovator in healthcare technology, is pleased to announce its participation in the upcoming 2024 American Clinical Neurophysiology Society (ACNS) Meeting in Orlando, Florida, from February 29 to March 2, 2024.
AES Orlando feature image

LVIS Corporation to Showcase Innovative Epilepsy Solution at the 2023 American Epilepsy Society Meeting

LVIS Corporation, a leading innovator in healthcare technology, is thrilled to announce its participation in the upcoming 2023 American Epilepsy Society (AES) Meeting in Orlando, Florida, from December 1 to 5.

We have an international team with our headquarters located in Palo Alto, California, USA, and offices in Gangnam, Seoul, Korea, and Daegu, Korea.

Palo Alto, California
Gangnam, Seoul, Korea
Daegu, Korea

© 2024 LVIS Corporation. All Rights Reserved.

LVIS has obtained regulatory clearance for NeuroMatch in the United States and Korea.
NeuroMatch United States FDA Clearance #: K222450
NeuroMatch Korea MFDS Clearance #: KTR-BABA-17212
Certain features shown are not yet cleared in the United States.